Eric D. Shaff, CEO and President: Seres Therapeutics MCRB Sell · Filed 25/05/19

Trade details

Type: Insider sale
Amount: $1,601.6
Shares · price: 220 sh · $7.28 a share
Held after: 10,102 sh
Stock: Seres Therapeutics MCRB
Person: Eric D. ShaffCEO and President
Trade date: 25/05/16
Filed: 25/05/19
Days to filing: 3 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

Seres Therapeutics trades, last 26 weeks

What else happened in Seres Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/16~25/06/15

Eric D. Shaff's recent trades

Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$1,950
259 sh
$1,950
Filed 05/19
Traded 05/18
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$2,194
259 sh
$2,194
Filed 02/18
Traded 02/15
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$3,754
217 sh
$3,754
Filed 25/11/18
Traded 25/11/15
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$3,613
217 sh
$3,613
Filed 25/08/19
Traded 25/08/18
Eric D. ShaffCEO and President
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$10.3K
12,726 sh
$10.3K
Filed 25/02/19
Traded 25/02/18